Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Jazz Pharmaceuticals (JAZZ) has a market cap of $7.35 billion USD. According to our data, Jazz Pharmaceuticals is ranked No.2093 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $7.35 B |
-1.24%
|
| Dec 31, 2024 | $7.44 B |
0.12%
|
| Dec 29, 2023 | $7.44 B |
-22.79%
|
| Dec 30, 2022 | $9.63 B |
25.05%
|
| Dec 31, 2021 | $7.70 B |
-22.81%
|
| Dec 31, 2020 | $9.98 B |
10.56%
|
| Dec 31, 2019 | $9.02 B |
20.43%
|
| Dec 31, 2018 | $7.49 B |
-7.94%
|
| Dec 29, 2017 | $8.14 B |
23.50%
|
| Dec 30, 2016 | $6.59 B |
-22.43%
|
| Dec 31, 2015 | $8.50 B |
-14.15%
|
| Dec 31, 2014 | $9.90 B |
29.37%
|
| Dec 31, 2013 | $7.65 B |
137.67%
|
| Dec 31, 2012 | $3.22 B |
37.85%
|
| Dec 30, 2011 | $2.34 B |
96.29%
|
| Dec 31, 2010 | $1.19 B |
149.75%
|
| Dec 31, 2009 | $0.48 B |
308.29%
|
| Dec 31, 2008 | $0.12 B |
-86.87%
|
| Dec 31, 2007 | $0.89 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Sarepta Therapeutics
SRPT
|
$11.08 B |
-0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.81 B |
-0.000 M
|
USA
|
 Alkermes
ALKS
|
$4.90 B |
0.000 M
|
Ireland
|
 Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
 Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$75.23 B |
1.245 B
|
USA
|
 Incyte
INCY
|
$14.05 B |
-0.000 M
|
USA
|
 Biogen
BIIB
|
$20.80 B |
-0.001 M
|
USA
|
 Jazz Pharmaceuticals
JAZZ
|
$7.35 B |
-0.000 M
|
Ireland
|
 AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
 Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
| Market Cap | = | JAZZ Stock Price | * | JAZZ Shares Outstanding |
| = | $121.62 | * | 60.45 M | |
| = | $7.35 B |